Single‐Atom Catalysts with Isolated Cu 1 ‐N 4 Sites for Atopic Dermatitis Cascade Catalytic Therapy via Activating PPAR Signaling
Small · 2024-12 · 20 (52)
DOI: 10.1002/smll.202407365 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 04.10.2024. Verfasst von Le Kuai und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Institute of Dermatology, Shanghai University of …. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Signal Transduction. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Atopic dermatitis (AD) is one of the most common allergic skin disorders affecting over 230 million people worldwide, while safe and efficient therapeutic options for AD are currently rarely available. Reactive oxygen species (ROS) accumulation plays a key role in AD's disease progression. Therefore, a novel single‐atom catalyst is designed with isolated Cu 1 ‐N 4 sites anchored on carbon support (Cu 1 ‐N 4 ISAC), featuring triple antioxidant enzyme‐mimicking activities, for efficient AD cascade catalytic therapy (CCT). The excellent superoxide dismutase (SOD)‐, glutathione peroxidase (GPx)‐, and ascorbate peroxidase (APx)‐like activities of Cu 1 ‐N 4 ISACs enable the sequential conversion of O 2 • − to H 2 O 2 and then to harmless H 2 O, thereby protecting keratinocytes from oxidative stress damage. Notably, two novel experimental methods are developed to directly prove the SOD‐GPx and SOD‐APx cascade catalytic activities for the first time. In vivo experiments show that Cu 1 ‐N 4 ISACs are more potent than a recommended typical medicine (halcinonide solution). Additionally, RNA sequencing and bioinformatic analysis reveal that Cu 1 ‐N 4 ISACs reduce inflammation and inhibit ROS production by activating PPAR signaling, which is aberrantly reduced in AD. Therefore, the synthesized catalytic medicine offers an alternative to alleviate AD and has the potential to serve as PPAR agonists for treating similar diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Institute of Dermatology, Shanghai University of Traditional Chinese Medicine, Shanghai, 200437, China.
- Department of Nephrology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China.
- Key Laboratory of Spine and Spinal Cord Injury Repair and Regeneration, Ministry of Education, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China.
- Department of Cardiology, Shanghai Tenth People's Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, School of Medicine, Tongji University, Shanghai, 200331, China.
- Shanghai Skin Disease Hospital, Institute of Dermatology, School of Medicine, Tongji University, Shanghai, 200443, China.
- School of Materials Science and Engineering, Hainan University, Haikou, 570228, China.
ORCID-Profile: Xiangyu Lu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai
- Fundamental Research Funds for the Central Universities
- Talent Program of Shanghai Municipal Health Commission
- Shanghai Dermatology Research Center
- Shanghai Dermatology Hospital demonstration research ward project
- Youth Talent Promotion Project of China Association of Traditional Chinese Medicine (2021-2023) Category A
- Health Young Talents of Shanghai Municipal Health Commission
Zitieren
APA
Kuai, L., Huang, F., Mao, L., Ru, Y., Jiang, J., Song, J., Chen, S., Li, K., Li, Y., Dong, H., Lu, X., Li, B., & Shi, J. (2024). Single‐Atom Catalysts with Isolated Cu 1 ‐N 4 Sites for Atopic Dermatitis Cascade Catalytic Therapy via Activating PPAR Signaling. Small, 20(52). https://doi.org/10.1002/smll.202407365
Vancouver
Kuai L, Huang F, Mao L, Ru Y, Jiang J, Song J, et al. Single‐Atom Catalysts with Isolated Cu 1 ‐N 4 Sites for Atopic Dermatitis Cascade Catalytic Therapy via Activating PPAR Signaling. Small. 2024;20(52). doi:10.1002/smll.202407365
BibTeX
@article{Kuai2024,
author = {Kuai, Le and Huang, Fang and Mao, Lijie and Ru, Yi and Jiang, Jingsi and Song, Jiankun and Chen, Si and Li, Ke and Li, Yongyong and Dong, Haiqing and Lu, Xiangyu and Li, Bin and Shi, Jianlin},
title = {Single‐Atom Catalysts with Isolated Cu 1 ‐N 4 Sites for Atopic Dermatitis Cascade Catalytic Therapy via Activating PPAR Signaling},
journal = {Small},
year = {2024},
volume = {20},
number = {52},
doi = {10.1002/smll.202407365}
}
EUVIMED